Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00279045 · ClinicalTrials.gov registry record · Phase 3
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 4,426
- Enrollment target
NCT00279045: Completed Phase 3 study, sponsored by GlaxoSmithKline.
NCT00279045 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 4,426 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (473% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00279045, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 4,426 participants
- Enrollment target
Study Summary
The study will compare and evaluate the effects of long-term treatment of monotherapy with rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of glycemic control in patients with recently diagnosed type 2 diabetes mellitus.
Interventions
- DRUG Rosiglitazone
- DRUG metformin
- DRUG glyburide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,426 participants |
| Start Date | 2000-01-03 |
| Est. Completion | 2006-06-19 |
| Phase | Phase 3 |
What the finished NCT00279045 record still lists
NCT00279045 is an interventional study that assigns participants to a tested intervention. Its 4,426 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (473% higher).
The record links to 0 conditions, and to 3 interventions - of which Rosiglitazone is the first listed.
NCT00279045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00279045 about?
NCT00279045 is a clinical study titled "Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide". The study will compare and evaluate the effects of long-term treatment of monotherapy with rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of glycemic control in patients with recently diagnosed type 2 diabetes mellitus.
What is the current status of trial NCT00279045?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,426 participants. The study started on 2000-01-03. Estimated completion is 2006-06-19.
What interventions are being tested in trial NCT00279045?
The interventions under investigation include: Rosiglitazone (DRUG), metformin (DRUG), glyburide (DRUG).
Who is sponsoring clinical trial NCT00279045?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00279045's enrollment target sits among peer trials
4,426 56th of 2000 higher than 1,945 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02660645 · 4,400 participants
Blue Light Cystoscopy With Cysview® Registry
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI